Social media

ADCs are transforming cancer treatment by combining targeted monoclonal antibodies with powerful cytotoxic agents. However their complexity poses bioanalytical challenges. Scientists face major challenges due to ADC he...

Understanding how clinical trials are delivered starts with clarity on the roles that shape them. Our latest blog explains how sponsors set the research agenda and retain oversight, how CROs manage operational delivery...

AI enabled SaMD is evolving quickly. But are we addressing model bias fast enough? Our latest blog explores how bias creeps into datasets and what developers must do to avoid perpetuating disparities in healthcare. - Im...

Regulatory change is coming to pediatric therapeutics. The EMA proposed a new MoA PIP requirement that could transform pediatric drug development and create an influx of more meaningful therapies. Learn from ICON exp...

ICON proudly supports International Childhood Cancer Day, reaffirming our commitment to advancing research and improving outcomes for children, survivors, and families affected by childhood cancer. In the past 5 years,...

As digital endpoints gain regulatory traction, sponsors who invest in endpoint strategy and validation today will be better positioned to run faster, more inclusive trials tomorrow. Digital health technologies are enabli...

Career progression is rarely linear, and there is no single path to leadership. In our latest blog, Sinéad McKeon discusses what drove her move from the lab bench to project management. She reflects on the capabilities...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

ICON provides comprehensive cardiac safety monitoring supported by a team of cardiovascular electrophysiology specialists, board certified cardiologists, radiologists, and medical experts. We offer protocol consulting,...

Looking forward to #ASCPT2026. Come along to the ICON partner hub for a chat and don’t miss our Learning Lab session on 5th March at 10:30 where we will be discussing considerations for the design, safety, pharmacokineti...

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine have developed PLATO 11, a validated, patient centred PRO tool designed to better capture the lived experience of people with obstructive sleep a...